Use the Back button in your browser to see the other results of your search or to select another record.
Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately high to highly emetogenic chemotherapy |
Treish I, Shord S, Valgus J, Harvey D, Nagy J, Stegal J, Lindley C |
Supportive Care in Cancer 2003 Aug;11(8):516-521 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: Yes; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|